Live feed16:05:00·405dPRReleasevia QuantisnowVaxart Publishes Positive, Complete Data from a Phase 2b Challenge Study of its First-Generation Oral Pill Norovirus Vaccine Candidate in Science Translational MedicineByQuantisnow·Wall Street's wire, on your screen.VXRT· Vaxart IncHealth Care
